Evolution of the legislative and administrative system of controlled drugs in Taiwan

Journal of Food and Drug Analysis

Volumn 20, Issue 4, 2012, Pages

  Li, Jih Heng ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Controlled drugs; Drug policy; Harm reduction; Legislation; Substance abuse; UN conventions

Indexed keywords

METHAMPHETAMINE; NARCOTIC AGENT;

COST EFFECTIVENESS ANALYSIS; DRUG LEGISLATION; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; EDUCATION PROGRAM; HUMAN; INFORMATION SYSTEM; LICENSING; MEDICAL SOCIETY; METHAMPHETAMINE DEPENDENCE; ORGANIZATION AND MANAGEMENT; REVIEW; SUBSTANCE ABUSE; TAIWAN;

EID: 84875273514     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Li, J. H. and Lin, L. F. 1998. Genetic toxicology of abused drugs: a brief review. Mutagenesis 13: 557-565.
2. United Nations Office on Drugs and Crime. October, 2010. A Century of International Drug Control. United Nations.
3. United Nations, 1961. Single Convention on Narcotic Drugs, United Nations.
4. United Nations, 1971. Convention on Psychotropic Substances, United Nations.
5. United Nations, 1988. Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, United Nations.
6. Li, J. H., Liu, S. F. and Yu, W. J. 2006. Patterns and trends of drug abuse in Taiwan: a brief history and report from 2000 through 2004. In "Epidemiologic trends in drug abuse, Vol II, Proceedings of the Community Epidemiology Work Group, 2005 June; Denver, CO." National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, U.S.A.
7. Government Gazette. 1929. Narcotics Control Act. Republic of China Government. Enacted on October 26, 1929; Promulgated on November 11, 1929. http://zh.wikisource.org/wiki/ %E9%BA%BB%E9%86%89%E8%97%A5%E5%93%81%E7%AE%A1%E7%90%86%E6%A2%9D%E4%BE%8B- (%E6%B0%91%E5%9C%8B18%E5%B9%B4) (accessed on July 9, 2012).
8. th anniversary of National Narcotics Bureau. National Narcotics Bureau, Department of Health, Taiwan, R.O.C.
9. WHO. 1996. Cancer Pain Relief. World Health Organization, Geneva.
10. Chin, F. S., Liu, S. F. and Li, J. H. 2003. History and development of narcotic supply for medical and scientific purposes in Taiwan. In "Substance Abuse" Part I, Chapter 5. pp. 60-69. Li, J.H. ed. National Bureau of Controlled Drugs, Department of Health, Taiwan, R.O.C.
11. Sun, W. Z., Hou, W. Y. and Li, J. H. 1996. Republic of China: Status of cancer pain and palliative care. Journal of Pain and Symptom Management. 12: 127-129.
12. Wu, S. C., Houng, G. H. and Hsieh, P. C. et al. 1996. Stability evaluation of oral controlled-release morphine sulfate tablets. The Chinese Pharmaceutical Journal. 48: 397-404.
13. Hsu, C. C. and Li, J. H. 1998. The trends of requirements in medical analgesics from 1987 through 1996 in Taiwan. Chinese Journal of Public Health 17: 495-503.
14. Li, J. H. 1998. Drug abuse situation and anti-drug programs in Taiwan, R.O.C. In "Report of the Asian Multicity Epidemiology Work Group 1997" International Monograph Series No. 11. pp. 151-156. Navaratnam, V. and Bakar A.A. eds. Centre for Drug Research, Universiti Sains Maylasia, Penang, Maylasia.
15. Ministry of Justice. 1995. "Annual Anti-Drug Report of 1994." Joint Task Force of Ministry of Justice, Ministry of Education, and Department of Health, R.O.C.
16. Presidential Gazette. No. 5599. July 27, 1992. Law for the Eradication of Illicit Narcotics.
17. Li, J. H. 1994. Report of visit to organizations for drug abuse prevention and control in the Netherlands, Belgium and Sweden, September 1994. National Narcotics Bureau, Department of Health, Taiwan, R.O.C.
18. Li, J. H. 1994. Report of visit to organizations for drug abuse prevention and control in the United States, November 1994. National Narcotics Bureau, Department of Health, Taiwan, R.O.C.
19. Li, J. H. 1994. Report of visit to organizations for drug abuse prevention and control in the Malaysia and Singapore, December 1994. National Narcotics Bureau, Department of Health, Taiwan, R.O.C.
20. Li, J. H. 1995. Report of Asian-Pacific Symposium on Drug Abuse held in Seoul, Korea, November 1995. National Narcotics Bureau, Department of Health, Taiwan, R.O.C.
21. Li, J. H. 1996. Report of visit to organizations for drug abuse prevention and control in the U.K., France and Germany, March 1996. National Narcotics Bureau, Department of Health, Taiwan, R.O.C.
22. Presidential Gazette, Taiwan, R.O.C. No. 8700099860. May 20, 1998. Law for Prevention and Control of Illicit Drug Hazard.
23. Presidential Gazette, Taiwan, R.O.C. No. 8800124380. June 2, 1999. Controlled Drugs Act.
24. Presidential Gazette, Taiwan, R.O.C. No. 8800124390. June 2, 1999. Act for the Organization of National Bureau of Controlled Drugs.
25. Li, J. H. and Lu, M. I. 2003. Patterns and trends of drug abuse in Taiwan, R.O.C.: Report of 1998 and 1999. In "Report of the Asian Multicity Epidemiology Work Group 2002" International Monograph Series No. 16. pp. 8-16. Navaratnam, V. and Wong, P-L. eds. Centre for Drug Research, Universiti Sains Maylasia, Penang, Maylasia.
26. McKetin, R., Kozel, N. and Douglas, J. et al. 2008. The rise of methamphetamine in Southeast and East Asia. Drug Alcohol Rev. 27: 220-228.
27. Lee, H. Y., Yang, Y. H. and Yu, W. J. et al. 2012. Essentiality of HIV testing and education for effective HIV control in the national pilot harm reduction program: The Taiwan experience. Kaohsiung J. Med. Sci. 28: 79-85.
28. Liu, S. F., Lee, P. C., Lu, M. I., Tsay, W. I. and Li, J. H. 2006. A survey on substance abuse in the Greater Taipei area. Taiwan Journal of Public Health 25: 274-282.
29. NHIS Task Force. 2007. 2005 Taiwan National Health Interview Survey (NHIS) Research Brief No. 10.
30. Liu, C., Tsay, W. I. and Li, J. H. 2001. Taiwan conducts urine tests as part of war on drugs. Clinical & Forensic Toxicology News. June 2001: 7-8.
31. Huang, M. K., Liu, C., Li. J. H. and Huang, S. D. 2005. Quantitative detection of ketamine, norketamine, and dehydronorketamine in urine chemical derivatization followed by gas chromatography-mass spectrometry. J. Chromatogr. B 820: 165-173. (Pubitemid 40724582)
32. Liu, C., Li, J. H., Tsay, W. I. and Hsu, J. 2005. Drug use and profile of individuals arrested on drug-related charges in Taiwan. J. Food Drug Anal. 13: 101-106.
33. Chen, D. N., Hsu, C. H., Chu, J. C. and Lai, J. S. 2003. Cause, theory and strategy of substance abuse. In "Substance Abuse" Part III, Chapter 2. pp. 416-423. Li, J. H. ed. National Bureau of Controlled Drugs, Department of Health, Taiwan, R.O.C.
34. Lee, C. C., Chu, J. C., Chen, D. N., Lai, J. S. and Li, J. H. 2005. Awareness of illegal drug use in senior and vocational high school students that participated in the antidrug ambassador campaign. Taiwan Journal of Public Health. 24: 224-229.
35. Yu, W. N., Hu, W. L. and Li, J. H. 1998. Preliminary estimation of the social cost on drug abuse in Taiwan, R.O.C. Chinese Journal of Public Health 17: 360-369.
36. Chen, Y. M. and Kuo, S. H. 2007. HIV-1 in Taiwan. Lancet. 369: 623-625.
37. Anonymous, 2010. Characteristics of Substance Abuse Treatment Admissions Reporting Primary Abuse of Prescription Pain Relievers: 1998 and 2008. The TEDS Report September 23, 2010, Substance Abuse and Mental Health Services Administration, U.S.A.
38. McKetin, R., Sutherland, R., Bright, D. A. and Norberg, M. M. 2011. A systematic review of methamphetamine precursor regulations. Addiction 106: 1911-1924.
39. Cunningham, J. K. and Liu, L. M. 2003. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. Addiction 98: 1229-1237. (Pubitemid 37082816)
40. Cunningham, J. K. and Liu, L. M. 2005. Impacts of federal precursor chemical regulations on methamphetamine arrests. Addiction 100: 479-488. (Pubitemid 40529840)
41. st Century", Chapter 12. pp. 133-151. Ghodse, H. ed. Ashgate Publishing Company. U.K.
42. Li, J. H., Vicknasingam, B. and Cheung, Y. W. et al. 2011. To use or not to use: an update on licit and illicit ketamine use. Substance Abuse and Rehabilitation. 2: 11-20.
43. Wu, L. T., Woody, G. E., Yang, C. M., Li, J. H. and Blazer, D. S. 2011. Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Substance Abuse and Rehabilitation 2: 53-68.
44. Nutt, D., King, L. A., Saulsbury, W., and Blakemore, C. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 369: 1047-1053. (Pubitemid 46436128)
45. Presidential Gazette, Taiwan, R.O.C. No. 10000015581. January 26, 2011. Controlled Drugs Act (revision).
46. Executive Yuan Council, Feburary 23, 2012. http://techsurvey.hamastar. com.tw/Upload/WebArchive/01-ey/20120328/www.ey.gov.tw/ctae6d.html?xItem= 87456&ctNode=4211&mp=1. (accessed on September 10, 2012)
47. Leshner, A. I. 2000. NIDA's Epidemiological Compasses. NIDA Notes 15:1.
48. Clayton, R., Cattarello, A. M. and Johnstone, B. M. 1996. The effectiveness of drug abuse resistance education (Project DARE): 5-year follow-up results. Preventive Medicine 25: 307-318.
49. Birkeland, S., Murphy-Graham, E. and Weiss, C. W. 2005. Good reasons for ignoring good evaluation: The case of the drug abuse resistance education (D.A.R.E.) program. Evaluation and Program Planning 28: 247-256. (Pubitemid 40935958)
50. Sindelar, J. L., Jofre-Bonet, M., French, M. T. and McLellan, A. T. 2004. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug and Alcohol dependence 73: 41-50. (Pubitemid 37542477)
51. Vanderplasschen, W., Wolf, J., Rapp, R. C. and Broekaert, E. 2007. Effectiveness of different models of case management for substance-abusing populations. Journal of Psychoactive Drugs 39: 81-95. (Pubitemid 46764235)
52. Mariani, J. J., Cheng, W. Y. and Bisaga, A. et al. 2011. Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants. Journal of Substance Treatment 40: 426-430.
53. Rydell, C. P. and Everingham, S. S. 1994. Alternative evaluation criteria. In "Controlling cocaine supply versus damand programs." Chapter 5. pp.35-42. Rydell, C. P. and Everingham, S. S. eds. Drug Policy Research Center. Rand, U.S.A.
54. Belenko, S. 2005. Economic benefits of drug treatment: A critical review of the evidence for policy makers. Treatment Research Institute at the University of Pennsylvania, U.S.A.